Clinical Trials in Czech Republic

Active recruiting clinical trials with sites in Czech Republic. Select a condition below to see detailed trial listings.

Total Trials: 69 // Recruiting: 69 // Updated: Daily

Czech Republic currently has 69 clinical trials with at least one registered site in the country, of which 69 are actively recruiting participants. The most studied conditions at Czech Republic sites are Heart Failure, Endometrial Cancer, Pancreatic Ductal Adenocarcinoma, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including University Hospital Ostrava, Charles University, Czech Republic, Masaryk University. By stage, active Czech Republic trials break down as Phase 1 (6), Phase 2 (9), Phase 3 (14). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Czech Republic

Heart Failure 2 Endometrial Cancer 2 Pancreatic Ductal Adenocarcinoma 2 Hereditary Diseases 2 Pancreatitis, Chronic 2 Critical Illness 2 Multiple Myeloma 2 Spasticity 1 Neurological Complication 1 Childhood Ependymoma 1 Major Depressive Disorder (MDD) 1 Chronic Kidney Disease 1 Renal Anemia 1 Paroxysmal Nocturnal Hemoglobinuria (PNH) 1 Paroxysmal Hemoglobinuria 1 Agitation Associated With Alzheimer's Disease Dementia 1 Ischemic Stroke 1 Emotional Disorder 1 Atrial Fibrillation, Persistent 1 Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia 1

All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology